JP2023549605A5 - - Google Patents
Info
- Publication number
- JP2023549605A5 JP2023549605A5 JP2023528411A JP2023528411A JP2023549605A5 JP 2023549605 A5 JP2023549605 A5 JP 2023549605A5 JP 2023528411 A JP2023528411 A JP 2023528411A JP 2023528411 A JP2023528411 A JP 2023528411A JP 2023549605 A5 JP2023549605 A5 JP 2023549605A5
- Authority
- JP
- Japan
- Prior art keywords
- bedaquiline
- weeks
- combination product
- administered
- pharmaceutical formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063113149P | 2020-11-12 | 2020-11-12 | |
| US63/113,149 | 2020-11-12 | ||
| PCT/EP2021/081193 WO2022101244A1 (en) | 2020-11-12 | 2021-11-10 | Combination of bedaquiline, ethambutol and a macrolide in the treatment of nontuberculous mycobacterial diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023549605A JP2023549605A (ja) | 2023-11-28 |
| JP2023549605A5 true JP2023549605A5 (https=) | 2024-11-27 |
Family
ID=78695693
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023528411A Pending JP2023549605A (ja) | 2020-11-12 | 2021-11-10 | 非結核性マイコバクテリア疾患の治療におけるベダキリン、エタンブトール、及びマクロライドの組合せ |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230346770A1 (https=) |
| EP (1) | EP4243800A1 (https=) |
| JP (1) | JP2023549605A (https=) |
| KR (1) | KR20230107275A (https=) |
| CN (1) | CN116406270A (https=) |
| TW (1) | TW202233168A (https=) |
| WO (1) | WO2022101244A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20250169098A (ko) | 2024-05-24 | 2025-12-02 | 주식회사 에이엔제이사이언스 | 티오펩타이드 화합물을 포함하는 비결핵 항산균 감염증의 예방, 개선 또는 치료용 조성물 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1527050T3 (da) | 2002-07-25 | 2010-07-19 | Janssen Pharmaceutica Nv | Quinolin-derivater og deres anvendelse som mycobakterielle inhibitorer |
| AU2005249231B2 (en) | 2004-05-28 | 2010-11-11 | Janssen Pharmaceutica N.V. | Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases |
| EE05394B1 (et) | 2004-12-24 | 2011-04-15 | Janssen Pharmaceutica N.V. | Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis |
| UA97813C2 (uk) | 2006-12-05 | 2012-03-26 | Янссен Фармацевтика Н.В. | Фумаратна сіль (альфа s, бета r)-6-бром-альфа-[2-(диметиламіно)етил]-2-метоксі-альфа-1-нафталеніл-бета-феніл-3-хінолінетанолу |
| LT3250182T (lt) * | 2015-01-27 | 2023-07-10 | Janssen Pharmaceutica Nv | Dispersinės kompozicijos |
| JOP20200004B1 (ar) * | 2017-07-14 | 2023-09-17 | Janssen Pharmaceutica Nv | تركيبات طويلة المفعول |
| WO2020144197A1 (en) * | 2019-01-09 | 2020-07-16 | Janssen Pharmaceutica Nv | Combination in the treatment of nontuberculous mycobacterial diseases |
-
2021
- 2021-11-10 CN CN202180075784.2A patent/CN116406270A/zh active Pending
- 2021-11-10 US US18/199,748 patent/US20230346770A1/en active Pending
- 2021-11-10 TW TW110141803A patent/TW202233168A/zh unknown
- 2021-11-10 JP JP2023528411A patent/JP2023549605A/ja active Pending
- 2021-11-10 EP EP21810566.6A patent/EP4243800A1/en active Pending
- 2021-11-10 WO PCT/EP2021/081193 patent/WO2022101244A1/en not_active Ceased
- 2021-11-10 KR KR1020237018777A patent/KR20230107275A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2314810C2 (ru) | Способ лечения с использованием лекарственных форм, содержащих фармацевтические композиции 5,8,14-триазатетрацикло[10.3.1.0 (2,11).0(4,9)] гексадека-2( 11),3,5,7,9-пентаена | |
| ES2925246T3 (es) | Formulaciones farmacéuticas que comprenden tenofovir y emtricitabina | |
| JP5726766B2 (ja) | ニタゾキサニドの制御放出医薬配合物 | |
| ES2524408T5 (es) | Composiciones terapéuticas que comprenden rilpivirina HCl y tenofovir disoproxil fumarato | |
| RU2404750C2 (ru) | Композиция, содержащая основу или покрытие для замедленного высвобождения и антагонист nmda рецептора, способ введения такого nmda антагониста субъекту | |
| HUE029677T2 (hu) | Készítmények centrálisan mediált émelygés és hányás kezelésére | |
| JPH06102622B2 (ja) | 肥満の治療 | |
| JP2006514092A5 (https=) | ||
| JP2019517542A5 (https=) | ||
| JP2010538066A5 (https=) | ||
| KR101951220B1 (ko) | 조합 als 치료법 | |
| JP2021509395A5 (https=) | ||
| CZ2004232A3 (cs) | Jednorázová dávka azithromycinu | |
| JP2022549621A5 (https=) | ||
| JP2023549605A5 (https=) | ||
| JP2024539476A5 (https=) | ||
| ES2286716T3 (es) | Composicion farmaceutica de liberacion controlada y proceso para preparar la misma. | |
| JP2022177119A5 (https=) | ||
| US20160184231A1 (en) | Anti-tuberculosis stable pharmaceutical composition in a form of a dispersible tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation | |
| JP2021503448A5 (https=) | ||
| US20090306204A1 (en) | Pharmaceutical Composition Comprising Cyclobenzaprine and Aceclofenac in Association | |
| JP2006508118A5 (https=) | ||
| CN102327599A (zh) | 用于治疗骨髓增生异常综合征的组合物和方法 | |
| JP2023533472A5 (https=) | ||
| JP2024531799A5 (https=) |